share_log

Passage Bio Tapped Kathleen Borthwick as CFO, Effective March 1

Passage Bio Tapped Kathleen Borthwick as CFO, Effective March 1

Passage Bio 聘請凱瑟琳·博思威克擔任首席財務官,自 3 月 1 日起生效
Moomoo 24/7 ·  03/04 07:07
  • Appointed Kathleen Borthwick as Chief Financial Officer, effective March 1, 2024: Ms. Borthwick previously served as the company's Senior Vice President, Finance and Interim CFO and brings 25 years of pharmaceutical and biotech strategic financial leadership experience.
  • 任命凱瑟琳·博思威克爲首席財務官,自2024年3月1日起生效:博思威克女士曾擔任公司高級副總裁、財務和臨時首席財務官,擁有25年的製藥和生物技術戰略財務領導經驗。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論